Vetter In Rankweil Gets Permanent Manufacturer Authorization
Vetter, which happens to be a global CDMO, has gone on to receive permanent manufacturer authorization as far as its clinical development site in...
Global Healthcare Access Improved By Indian Pharma Cos.
As per Indian Government Union Minister Bhagwanth Khuba, Indian pharmaceutical companies have gone on to emerge as dependable and cost-effective options when it comes...
Biden Designates 31 Tech Hubs, With 10 For Pharma, Biotech
Traditionally, the tech as well as the biotech sectors across the US have been existing in a handful of regions, such as Silicon Valley....
Unlocking The Possibilities of Point-of-Care Manufacturing
It is well to be noted that biopharma production in today’s times takes place in the centralised manufacturing setups. Industry as well as regulators...
Machine Conditioning Monitoring – Making Inroads In Pharma
The pharma industry relies extensively on the trust when it comes to consumers as well as communities. As a result, it remains a very...
Predictive Maintenance – AI Aspect In Pharma Manufacturing
Pharmaceutical manufacturing happens to be a highly challenging and precise process that is crucial and has a prominent impact across various industries. One of...
Industry 5.0 Has Plenty To Offer To Pharma Manufacturing
In the last dozen years, Industry 4.0 has brought about a significant transformation when it comes to manufacturing technology. It has enabled machines to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...



























